A detailed history of Simplex Trading, LLC transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Simplex Trading, LLC holds 871 shares of IMCR stock, worth $24,614. This represents 0.0% of its overall portfolio holdings.

Number of Shares
871
Holding current value
$24,614
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$30.06 - $41.49 $26,182 - $36,137
871 New
871 $27,000
Q3 2023

Nov 01, 2023

BUY
$49.5 - $66.6 $88,753 - $119,413
1,793 New
1,793 $93,000
Q1 2023

Apr 27, 2023

BUY
$46.12 - $65.71 $64,291 - $91,599
1,394 New
1,394 $68,000
Q3 2022

Nov 04, 2022

SELL
$37.34 - $57.44 $1,045 - $1,608
-28 Reduced 5.6%
472 $22,000
Q2 2022

Aug 03, 2022

SELL
$25.46 - $37.72 $4,735 - $7,015
-186 Reduced 27.11%
500 $18,000
Q1 2022

May 02, 2022

BUY
$18.94 - $34.29 $12,992 - $23,522
686 New
686 $20,000

Others Institutions Holding IMCR

About Immunocore Holdings plc


  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.24B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.